Marek Krogulec

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Eli Lilly (United States)22.3%
• Pfizer (United States)10.7%
• AbbVie (United States)7.6%
• University of Occupational and Environmental Health Japan7%
• Medical University of Vienna6.7%
• Leiden University Medical Center5.8%
• Other40%

Fields

• Medicine85.5%
• Immunology and Microbiology7.6%
• Biochemistry, Genetics and Molecular Biology5.2%
• Neuroscience0.7%
• Computer Science0.3%
• Pharmacology, Toxicology and Pharmaceutics0.3%
• Other0.3%

Topics

• Rheumatoid Arthritis Research and Therapies32.5%
• Spondyloarthritis Studies and Treatments15.4%
• Autoimmune and Inflammatory Disorders Research13.3%
• Cytokine Signaling Pathways and Interactions7.3%
• Systemic Lupus Erythematosus Research6.9%
• Psoriasis: Treatment and Pathogenesis5.8%
• Other18.8%